News
Elan Drug Technologies Announces Completion of Enrolment in Phase 3
Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Zogenix Inc, its licensee, has completed enrolment in its open-label Phase 3...
Industry Reports
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011, to US$880 billion, compared with a 4-5 percent pace...
Press Releases
Next-Generation Cell Sorter from Beckman Coulter Enables Multi-Color Flow Cytometry Studies
MoFlo Astrios next-generation cell sorter from Beckman Coulter, Inc. leverages the stable fluidic design of the original MoFlo and the electronic processing of the...
Clinical Trials
Phase III study showed Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80% by Roche
Roche announced positive data from a Phase III study of Rituxan/MabThera (rituximab) in patients with advanced follicular lymphoma who did not have symptoms of...
News
Aurobindo Pharma receives FDA tentative approval for Duloxetine Hydrochloride Delayed Release Capsules
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US FDA to manufacture and market Duloxetine Hydrochloride...
Press Releases
Life Technologies Wins Top Ten Innovations of the Year Award
LifeTechnologies Corporation announced that its Applied Biosystems Attune(TM) Acoustic Focusing Cytometer has been named one of the Top Ten Innovations of 2010 by The...
Clinical Trials
QR Pharma receives FDA clearance to conduct clinical trials with its second novel Alzheimer compound
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that the United States Food and Drug Administration...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read